参考文献/References:
[1]Halpin D,Criner GJ,Papi A,et al.Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease[J].Am J Respir Crit Care Med,2021,203(1):24-36.[2]Wang C,Xu J,Yang L,et al.Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study[J].Lancet,2018,391(10131):1706-1717.[3]Rachner TD,Khosla S,Hofbauer LC.Osteoporosis: now and the future[J].Lancet,2011,377(9773):1276-1287.[4]夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J].中国骨质疏松杂志,2019,25(3):281-309.[5]Cecins E,Cavalheri V,Taaffe DR,et al.Prevalence of suspected poor bone health in people with chronic obstructive pulmonary disease - a cross-sectional exploratory study[J].Chron Respir Dis,2022,19:231422547.[6]Wan Q,Schoenmaker T,Jansen ID,et al.Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone[J].Bone,2016,86:10-21.[7]Chen YW,Coxson HO,Coupal TM,et al.The contribution of thoracic vertebral deformity and arthropathy to trunk pain in patients with chronic obstructive pulmonary disease (COPD)[J].Respir Med,2018,137:115-122.[8]Vilgelm AE.Illuminating the mechanism of IL-6-mediated immunotherapy resistance[J].Cell Rep Med,2023,4(1):100901.[9]Xu J,Lin H,Wu G,et al.IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma[J].Front Oncol, 2021,11:760971.[10]Mannion JM,McLoughlin RM,Lalor SJ.The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease[J].Clin Rev Allergy Immunol,2023,64(2):161-178.[11]Fischer V,Haffner-Luntzer M.Interaction between bone and immune cells: Implications for postmenopausal osteoporosis[J].Semin Cell Dev Biol,2022,123:14-21.[12]Li Y,Lu L,Xie Y,et al.Interleukin-6 Knockout Inhibits Senescence of Bone Mesenchymal Stem Cells in High-Fat Diet-Induced Bone Loss[J].Front Endocrinol (Lausanne),2020,11:622950.[13]Eastell R,O’Neill TW,Hofbauer LC,et al.Postmenopausal osteoporosis[J].Nat Rev Dis Primers,2016,2:16069.[14]Jordan RE,Miller MR,Lam KB,et al.Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England[J].Thorax,2012,67(7):600-605.[15]Amaral A,Strachan DP,Burney P,et al.Female Smokers Are at Greater Risk of Airflow Obstruction Than Male Smokers. UK Biobank[J].Am J Respir Crit Care Med,2017,195(9):1226-1235.[16]Gut-Gobert C,Cavailles A,Dixmier A,et al.Women and COPD: do we need more evidence?[J].Eur Respir Rev,2019,28(151):180055.[17]Zysman M,Raherison-Semjen C.Women’s COPD[J].Front Med (Lausanne),2021,8:600107.[18]Zhao K,Dong R,Yu Y,et al.Cigarette smoke-induced lung inflammation in COPD mediated via CCR1/JAK/STAT /NF-kappaB pathway[J].Aging (Albany NY),2020,12(10):9125-9138.[19]Strowitzki MJ,Cummins EP,Taylor CT.Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?[J].Cells,2019,8(5):384.[20]Zhang HX,Yang JJ,Zhang SA,et al.HIF-1alpha promotes inflammatory response of chronic obstructive pulmonary disease by activating EGFR/PI3K/AKT pathway[J].Eur Rev Med Pharmacol Sci,2018,22(18):6077-6084.[21]Kaneshiro S,Ebina K,Shi K,et al.IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro[J].J Bone Miner Metab,2014,32(4):378-392.[22]Groetsch B,Schachtschabel E,Tripal P,et al.Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts[J].Front Immunol,2022,13:958974.[23]Xu L,Zhang L,Zhang H,et al.The participation of fibroblast growth factor 23 (FGF23) in the progression of osteoporosis via JAK/STAT pathway[J].J Cell Biochem,2018,119(5):3819-3828.[24]Damerau A,Gaber T,Ohrndorf S,et al.JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration[J].Int J Mol Sci,2020,21(23):9004.[25]Meng X,Lin Z,Cao S,et al.Estrogen-mediated downregulation of HIF-1alpha signaling in B lymphocytes influences postmenopausal bone loss[J].Bone Res,2022,10(1):15.[26]Zhu J,Tang Y,Wu Q,et al.HIF-1alpha facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro[J].J Cell Physiol,2019,234(11):21182-21192.[27]Xi JC,Zang HY,Guo LX,et al.The PI3K/AKT cell signaling pathway is involved in regulation of osteoporosis[J].J Recept Signal Transduct Res,2015,35(6):640-645.
相似文献/References:
[1]汪钦生,邵 敏,姜 涛.绝经后妇女中骨质疏松患者血清钙磷、骨代谢指标与BMD的关系[J].医学信息,2019,32(04):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
WANG Qin-sheng,SHAO Min,JIANG Tao.Relationship between Serum Calcium,Phosphorus and Bone Metabolism Markers and BMD in Postmenopausal Women with Osteoporosis[J].Journal of Medical Information,2019,32(17):1.[doi:10.3969/j.issn.1006-1959.2019.04.001]
[2]杨宵月,李建伟.LncRNA调控人类疾病关系数据库的研究[J].医学信息,2019,32(12):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
YANG Xiao-yue,LI Jian-wei.LncRNA Regulation of Human Disease Relationship Database[J].Journal of Medical Information,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
[3]操利超,张核子,余晨笛,等.CLDN11在结肠癌中的预后价值及其作为潜在免疫治疗靶点的研究[J].医学信息,2022,35(14):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
CAO Li-chao,ZHANG He-zi,YU Chen-di,et al.The Prognostic Value of CLDN11 in Colon Cancer and its Potential Immunotherapy Targets[J].Journal of Medical Information,2022,35(17):10.[doi:10.3969/j.issn.1006-1959.2022.14.002]
[4]王婷婷,温凌杜,王子弘,等.基于DNA甲基化鉴定口腔鳞状细胞癌预后生物标志物[J].医学信息,2022,35(13):28.[doi:10.3969/j.issn.1006-1959.2022.13.005]
WANG Ting-ting,WEN Ling-du,WANG Zi-hong,et al.Identification of Prognostic Biomarkers for Oral Squamous Cell Carcinoma Based on DNA Methylation[J].Journal of Medical Information,2022,35(17):28.[doi:10.3969/j.issn.1006-1959.2022.13.005]
[5]冯欢欢.骨质疏松症中医理论研究的文献计量学分析[J].医学信息,2022,35(16):28.[doi:10.3969/j.issn.1006-1959.2022.16.006]
FENG Huan-huan.Bibliometric Analysis of TCM Theoretical Research on Osteoporosis[J].Journal of Medical Information,2022,35(17):28.[doi:10.3969/j.issn.1006-1959.2022.16.006]
[6]黄琪峰,郑琳琳,张 菁.甲状腺癌中miR-222关键靶基因预测及其信号通路分析[J].医学信息,2020,33(01):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Prediction of Key Target Genes of miR-222 in Thyroid Cancer and Analysis of Its Signal Pathway[J].Journal of Medical Information,2020,33(17):85.[doi:10.3969/j.issn.1006-1959.2020.01.026]
[7]李熹阳,谷明宇,华 琳.影响前列腺癌风险的关键基因识别[J].医学信息,2020,33(02):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
LI Xi-yang,GU Ming-yu,HUA Lin.Identification of Key Genes Affecting Prostate Cancer Risk[J].Journal of Medical Information,2020,33(17):80.[doi:10.3969/j.issn.1006-1959.2020.02.022]
[8]黄 成,易尚辉,查文婷,等.基于生物信息学分析筛选舌鳞状细胞癌核心基因及其预后价值[J].医学信息,2020,33(03):6.[doi:10.3969/j.issn.1006-1959.2020.03.002]
HUANG Cheng,YI Shang-hui,ZHA Wen-ting,et al.Screening Core Genes of Tongue Squamous Cell Carcinoma Based on Bioinformatics Analysis and Its Prognostic Value[J].Journal of Medical Information,2020,33(17):6.[doi:10.3969/j.issn.1006-1959.2020.03.002]
[9]吴超颖,陈 冬,吴超群,等.头颈部鳞状细胞癌预后相关的miRNAs的生物信息学分析[J].医学信息,2020,33(02):61.[doi:10.3969/j.issn.1006-1959.2020.02.017]
WU Chao-ying,CHEN Dong,WU Chao-qun,et al.Bioinformatics Analysis of Prognosis-related miRNAs in Head and Neck Squamous Cell Carcinoma[J].Journal of Medical Information,2020,33(17):61.[doi:10.3969/j.issn.1006-1959.2020.02.017]
[10]胡昕倩,余雅婕,方 明.垂体瘤的基因芯片数据生物信息学分析[J].医学信息,2020,33(06):90.[doi:10.3969/j.issn.1006-1959.2020.06.026]
HU Xin-qian,YU Ya-jie,FANG Ming.Bioinformatics Analysis of Gene Chip Data for Pituitary Tumors[J].Journal of Medical Information,2020,33(17):90.[doi:10.3969/j.issn.1006-1959.2020.06.026]
[11]汪 青,黄昊强,陈 勇,等.基于生物信息学分析二仙汤治疗膝关节骨性关节炎合并骨质疏松症的机制[J].医学信息,2024,37(06):1.[doi:10.3969/j.issn.1006-1959.2024.06.001]
WANG Qing,HUANG Hao-qiang,CHEN Yong,et al.Mechanism of Erxian Decoction in the Treatment of Knee Osteoarthritis with Osteoporosis Based on Bioinformatics Analysis[J].Journal of Medical Information,2024,37(17):1.[doi:10.3969/j.issn.1006-1959.2024.06.001]